immunity after vaccination seems to be weaker and is probably of shorter duration because previously vaccinated patients have been reported occasionally to contract In seronegative autologous bone marrow transplanted (ABMT) patients, a sustained cell-mediated immunity measles. 3, 4 Patients who have undergone bone marrow transplantation have a continuous decrease in immunity to (CMI) has been shown to impair the antibody response after measles vaccination. To investigate if this might measles over time after transplantation, and there are individuals who lose either B or T cell immunity, or both.
Summary:
immunity after vaccination seems to be weaker and is probably of shorter duration because previously vaccinated patients have been reported occasionally to contract In seronegative autologous bone marrow transplanted (ABMT) patients, a sustained cell-mediated immunity measles. 3, 4 Patients who have undergone bone marrow transplantation have a continuous decrease in immunity to (CMI) has been shown to impair the antibody response after measles vaccination. To investigate if this might measles over time after transplantation, and there are individuals who lose either B or T cell immunity, or both. [5] [6] [7] be caused by a preferential Th1 cytokine response, interferon (IFN)-␥ and interleukin (IL)-10 production When patients were vaccinated against measles after autologous bone marrow transplantation (ABMT), they surprisof peripheral blood mononuclear cells (PBMC) was analyzed after measles antigen (M-ag) stimulation in vitro.
ingly seroconverted in a lower frequency than patients vaccinated after allogeneic bone marrow transplantation The non-specific immune response was measured by IFN-␣, and IL-12 analyses. Fifty non-vaccinated (BMT). 7 However, many of the seronegative patients who did not respond to vaccination after ABMT had a remaining patients following ABMT or allogeneic bone marrow transplantation (BMT) were included. IFN-␥ pro-T cell response to measles. Further investigation showed a negative correlation between antibody production and T duction was significantly higher in patients with a retained CMI to measles than in patients without (2. 3 cell reactivity prior to vaccination, whereas pre-existing low levels of measles antibodies did not influence the vs 0.8 IU/ml; P = 0.01). Only a non-significant tendency was seen in IL-10 production (48.6 vs 26.7 pg/ml; NS), results.
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In mice, subsets of T cells may be activated via T helper whereas no difference was found in IFN-␣ or IL-12 production. A positive correlation between IFN-␥ and ILtype (h) 1 or Th2 pathways, which are characterized by their different cytokine patterns. 9 Also, in humans, although 10 production was found (r s = 0.49; P Ͻ 0.001). After vaccination of 14 ABMT children, there was an increase less clearly, data suggest similar subsets of T cells.
10,11
Interferon-␥ (IFN-␥) and interleukin-2 (IL-2) have been in PBMC IFN-␥ production in vitro (2.5 vs Ͻ0.1 IU/ml; P Ͻ 0.05), whereas no changes were seen in the IL-10, associated with the Th1 response, whereas interleukin-4 (IL-4), interleukin-5, and interleukin-10 (IL-10) have been IFN-␣, or antibody levels. These results suggest that both Th1 and Th2 cytokine production are increased by associated with the Th2 response. 11,12 The Th1 pathway leads to stimulation of the cell-mediated immune response, M-ag stimulation in patients with a retained CMI to measles, but the Th1 response seems to be stronger. The activation of macrophages, and formation of some types of antibodies (IgM and IgG2a in the mouse), whereas the Th2 preferential Th1 stimulation and increase in IFN-␥ production after vaccination may lead to a reduction in the pathway leads to stimulation of the humoral immune response. 12-14 A reciprocal inhibition of the pathways has humoral immune response which may explain the negative correlation between antibody production and T cell also been shown, because IL-4 and IL-10 inhibit Th1 response and IFN-␥ inhibits Th2 response.
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reactivity prior to vaccination. Keywords: measles; immunity; interferon-␥; interleukinPrevious results in bone marrow transplanted patients, that high T cell reactivity to measles correlated with low 10; interleukin-12; vaccination antibody production following vaccination, led us to the hypothesis that remaining T memory cells might be stimulated preferentially via the Th1 pathway and thereby inhibit Following naturally acquired measles infection most indithe Th2 response and antibody production, in contrast to viduals develop both a humoral and a cellular immunity healthy individuals in whom data suggest a preferential to measles that is thought to be retained life-long. 1, 2 The stimulation via the Th2 pathway. 17, 18 Thus, the aims of the present investigation were: (1) to compare the T cell responses by means of peripheral blood mononuclear cell Correspondence: Dr K Pauksen, Department of Infectious Diseases, and without a retained cellular immunity (CMI); (2) to RFAL3 (anti-CD10) was used, in six children with c-ALL, both RFAL3 (anti-CD10) and SB4 (anti-CD19) were used, determine if there are differences between ABMT and BMT patients; and (3) to analyze the Th1 and Th2 cytokine and in two children with T-ALL, RFT2 (anti-CD7) was used. In one adult patient with lymphoma, SB4 (anti-CD19) production before and after measles vaccination in children who have undergone ABMT. In addition, IL-12 and IFNwas used. Following BMT, T cell depletion was performed in three adult patients with CML, in one with RFT8 (anti-␣ were analyzed, because these cytokines are produced by antigen presenting cells (APC) such as macrophages/ CD8) and RFT12 (anti-CD6), and in two patients with RFT2 (anti-CD7), RFT8 (anti-CD8), and RFT12 (antimonocytes and dendritic cells.
19-21 CD6).

Materials and methods
Measles vaccination after transplantation
Patients Antibodies to measles were tested regularly for all transplanted patients at their annual follow-up visit. Fourteen The immune response after M-ag stimulation was studied seronegative children who had undergone ABMT were vacin 50 patients following bone marrow transplantation who cinated with a live attenuated tri-valent vaccine directed had not been vaccinated against measles or contracted against measles, mumps, and rubella (Measles-Mumpsmeasles post-transplant. Furthermore, 13 children following Rubella-vaccine; Merck, Sharp and Dohme, Rahway, NJ, ABMT were studied after measles vaccination. Altogether USA). All vaccinated ABMT patients were in complete 63 patients (five children and seven adults after BMT, and remission and had no immunosuppressive treatment. The 23 children and 28 adults after ABMT) who were in comvaccination was administered at the earliest 1 year after plete remission from their hematologic disease, and who transplantation. visited the University Hospitals of Uppsala or Huddinge during 1992 and 1993, were studied at their annual followup. The patients had been transplanted between 1 and 7 Serology years earlier. Blood samples for serology and lymphocyte proliferation were taken concomitantly. Patient characterExamination for IgG antibodies to measles virus was performed using an antibody ELISA, as described preistics are presented in Table 1. viously. 25 The serum samples were stored at −20°C pending analysis. The cut-off for measles immunity has been Transplantation procedure determined by comparison with well-defined immuno assays such as the hemagglutination and neutralization test The transplantation procedure and marrow purging with monoclonal antibodies have been previously described in for measles. 25 Patients were regarded as seronegative if the antibody titer in measles IgG ELISA was Ͻ1000 and a detail. [22] [23] [24] Marrow purging was performed in 16 patients who underwent ABMT. In seven children with c-ALL, titer of у1000 was regarded as an indication of immunity. The table shows all patients who were included in the study: both non-vaccinated and vaccinated patients. n = number of patients; CR = complete remission. a Median age at transplantation. Range within brackets. b Median time interval between transplantation and collection of blood samples. Range within brackets.
Response to vaccination was defined as seroconversion to noassay method EASIA (Medgenix Diagnostics, Fleurus, Belgium). sIL-2R and sCD8 were measured by the immuan antibody titer of у1000 in the measles IgG ELISA.
noassay method EIA (T cell diagnostics, Cambridge, MA, USA). IL-12 was measured by the immunoassay method Lymphoproliferative response ELISA (R/D Systems Europe Ltd, Abingdon, Oxon, UK). The immunoassay for human IFN-␣ was a dissociationFresh PBMC were obtained by Ficoll (Pharmacia Fine Chemicals, Uppsala, Sweden) separation. The proliferation enhanced lanthanide fluoroimmunoassay (DELFIA) similar to that described for porcine IFN-␣, 29 except that murine assay was performed as previously described. 7 Briefly, for stimulation 0.1 ml of the measles Lec strain complement mAbs reactive with human IFN-␣ was used. In brief, the murine anti-huIFN-␣ mAbs LT27:293 and LT27:273 in fixation antigen (M-ag; Swedish Institute for Infectious Disease Control, Stockholm, Sweden), measles control PBS (2 g/ml) were used to coat the wells of flat-bottomed 96-well immunoplates. After postcoating, plates were incuantigen (C-ag) diluted 1/5 in medium, 25 g/ml phytohemagglutinin (PHA; Dakopatts, Copenhagen, Denmark) or bated for 2 h with samples diluted with at least equal volumes of dilution buffer which, in the present DELFIA, medium alone was used. After 6 days of incubation, 1 Ci of 3 H-thymidine was added and the incorporated activity included 40 g per ml of murine monoclonal IgG1. After washing, wells were incubated for 1 h with the murine antiwas measured in a scintillation counter as counts per minute (c.p.m. H-thymidine incorporations, and discriminates well between seropositive and seronegative ELISA titers. In children, the production of cytokines after healthy controls. 26, 27 Thus, a c.p.m. count у1000 was arbi-M-ag stimulation before and after measles vaccination, was trarily chosen prior to the study as an indication of the prescompared using the Mann-Whitney U test, and in the ence of reactive measles T memory cells, and Ͻ1000 c.p.m.
children from whom there were samples before and after as an indication of the lack of T memory cells to M-ag.
vaccination by the Wilcoxon signed rank test. The whole cell measles virus preparation used was tested in cell cultures without having any signs of cytotoxicity or remaining infectious viruses.
Results
Cytokine analyses Cytokine production after M-ag stimulation
Fifty (12 BMT and 38 ABMT) patients not vaccinated after The supernatants were collected on day 6 before the addition of 3 H-thymidine to the cells for cytokine analyses transplantation, were subgrouped according to positive or negative proliferative response to M-ag stimulation. As after PHA, M-ag and C-ag stimulation of PBMC. The collected volume of the supernatants from the five wells of shown in Table 2 , ABMT patients with a positive M-ag stimulation had higher IFN-␥ levels than patients with a each experiment was approximately 0.35-0.5 ml. Because several different cytokine analyses were performed, the volnegative stimulation (2.4 vs 0.8 IU/ml; P Ͻ 0.05). A similar tendency was also observed in BMT patients (2.3 vs 0.9 ume of the supernatants was not sufficient for all cytokine analyses. The number of analyses performed for each cyto-IU/ml; NS). IL-4 was not found in any of the patients. After both kine is shown in Table 2 . In a pilot study, 14 samples from ABMT patients were analyzed for soluble (s)IL-2 receptor ABMT and BMT, there was a tendency for higher IL-10 production in patients with a positive M-ag stimulation than (R) and sCD8. 28 Then IFN-␥ and IL-4 were concomitantly analyzed in all patients. Thereafter IFN-␣, IL-10, and in patients with a negative stimulation (45.9 vs 26.7 pg/ml; NS, and 60.9 vs 23.8 pg/ml; NS, respectively; Table 2 ). No finally IL-12 was analyzed.
The supernatant cytokine levels were determined using differences were found with respect to the IFN-␣ or IL-12 production between patients with a positive M-ag stimucommercial kits, according to the manufacturer's instructions. IFN-␥, IL-4 and IL-10 were measured by the immulation and to those with a negative one, Table 2 . Among the patient groups, there were no significant difseven remained seronegative after vaccination. In one child, blood samples were obtained only before vaccination. The ferences in 3 H-thymidine incorporation or cytokine responses to the non-specific mitogen PHA (data not cytokine production was analyzed in samples of PBMCs obtained from seven children before and from 13 children shown).
3 months to 1 year after vaccination. The IFN-␥ production was higher in the samples obtained from vaccinated chilCorrelations between cytokine levels after M-ag dren than in those from non-vaccinated (2.5 vs Ͻ0.1 IU/ml; stimulation P Ͻ 0.05), whereas there were no differences in IL-10 and The IFN-␥ levels were correlated with IL-10 levels both in IFN-␣ production or in 3 H-thymidine incorporation ABMT patients (r s = 0.38, P Ͻ 0.05) and in BMT patients (Table 4 ). (r s = 0.76, P = 0.01). If ABMT and BMT patients are taken
In six children in whom samples were obtained both together, there was a significant correlation between IFNbefore and after vaccination, the IFN-␥ production was sig-␣ and IL-10 levels (r s = 0.47, P Ͻ 0.01), and there was a nificantly higher after vaccination than before (1.9 vs correlation between IFN-␥ and IL-10 (r s = 0.49, Ͻ0.1 IU/ml; P Ͻ 0.05), whereas no differences were seen P Ͻ 0.001), whereas there was none between IFN-␣ and for IL-10, IFN-␣ or 3 H-thymidine incorporation (data not IFN-␥ levels. Furthermore, IL-12 levels did not correlate shown). There was a tendency for IFN-␥ production to be with any of the other cytokines. The proliferative response higher in the three children who did not seroconvert than after M-ag stimulation and the IgG antibody levels to in the three who did (6.3 vs 1.7 IU/ml; NS). measles in serum failed to correlate significantly with any of the measured cytokines.
Discussion Levels of IFN-␥, sIL-2R and sCD8 after M-ag, and C-ag
To characterize regulatory functions in the cell-mediated stimulation immune response, cytokine analyses were performed based In the 50 non-vaccinated patients the M-ag preparation on the Th1/Th2 hypothesis after M-ag stimulation. It was stimulated PBMC to higher IFN-␥ production than the Cfound that cytokine responses to M-ag and PHA were simiag preparation (2.0 vs 0.9 IU/ml; P Ͻ 0.001). To test if lar in patients following ABMT and BMT. These two cytotoxic/suppressor CD8 + T cells, which also can produce groups are therefore considered together in the present dis-IFN-␥, were activated after M-ag stimulation, sCD8 and cussion. sIL-2R were analyzed. As shown in Table 3 , the M-ag
Patients with retained T cell reactivity to M-ag had stimulated higher sIL-2R production than the C-ag prephigher production of the Th1 cytokine IFN-␥ than patients aration, whereas levels of sCD8, which is released after who had lost their T cell reactivity. Furthermore, our results activation of cytotoxic/suppressor CD8 + T cells, were not with high sIL-2R and low sCD8 levels indicate that mainly augmented. Thus, the results suggest that CD4
+ T cells CD4 + T cells were activated. [30] [31] [32] Thus, these results sugwere the main IFN-␥ source in our experiment.
gest that IFN-␥ is involved in the activation of T memory cells after specific M-ag stimulation in bone marrow transCytokine production after M-ag stimulation, before and planted patients.
after measles vaccination
In this study, no production of the Th2 cytokine IL-4 from PBMC was detected. The reason for this is probably Fourteen children who were seronegative for measles were vaccinated after ABMT. Six patients seroconverted and a short turn-over time of the cytokine. However, IL-10 has 321 Table 3 sIL-2R and sCD8 levels after PHA, measles and control antigen stimulation of PBMC from 14 ABMT patients 
sIL2-R = soluble interleukin-2 receptor; sCD8 = soluble CD8; PHA = phytohemagglutinin; M-ag = measles antigen; C-ag = control antigen; n = number of patients. 
M-ag c.p.m. 11 600 8800 0.29 range 400-88 900 0-54 300 (n) (7)
IgG 700 1200 0.16 range 0-950 0-12 000 (n) (7) also been regarded as a Th2 cytokine.
14,16 After both lation in vitro in bone marrow transplanted patients, but the Th1 response seems to be stronger. ABMT and BMT there was a non-significant tendency for a higher IL-10 production in patients with retained T cell IL-12, which can also be produced by APC, is proposed to direct T cells into the Th1 pathway and thus to promote memory to measles than in patients without. There was also a positive correlation between IL-10 and IFN-␥ production.
the cell-mediated immune response and IFN-␥ production. 19, 34 In the present study, IL-12 could only be anaThese results suggest that both Th1 and Th2 cytokines were activated after M-ag stimulation. One explanation of the lyzed in about half of the patients, the production was low, and no significant differences between patients with and finding that there was no significant difference in the IL-10 production between donors with and without a significant without retained T cell memory against measles were found. However, additional studies are warranted since ILlymphoproliferative response to M-ag, may be a weaker Th2 than Th1 response. However, it may also be explained 12 seems to be an important cytokine in the defense against measles virus.
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by a concomitant IL-10 production occurring in macrophages/monocytes, independently of the immune status of In healthy individuals an increased spontaneous IL-4 production and an unchanged IFN-␥ production by PBMCs in the donors. This is supported by the positive correlation between IL-10 and IFN-␣ found in our study and previous vitro have been shown after measles vaccination. 17 Furthermore, it has been suggested that there is a preferential actiresults demonstrating that both macrophages/monocytes and activated T memory cells can be sources of IL-10.
vation of CD4
+ Th2 cells in convalescence after natural measles.
18 However, another study has shown increased However, the IFN-␣ results indicate that the macrophage/monocyte cytokine contribution was similar in IFN-␥ levels in vitro after vaccination in healthy children.
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In our vaccination study, which was performed in order patients with and without retained T cell memory.
Thus, taken together, the results in cytokine production to determine the effect of in vivo measles antigen stimulation on in vitro Th1 and Th2 cytokine production, it was in patients with and without a T cell response, the correlations in cytokine responses, and the increase in sIL-2R
shown that children who were vaccinated against measles after ABMT had a higher IFN-␥ production 1 year after indicate both a Th1 and a Th2 response after M-ag stimu-term immunity to measles, mumps, and rubella after allogvaccination in comparison with prevaccination levels, eneic bone marrow transplantation. Blood 1994; 84: 657-663.
whereas there were no differences in lymphocyte prolifer- and IFN-␥ production may still have some protection, at 2081-2095. least against the more fulminant forms of measles. 
